PerspectiveRevised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature1☆,
Section snippets
Participants in the first international workshop on Vogt-Koyangi-Harada disease
Massimo Accorinti, MD (Rome, Italy), Lourdes Arellanes-Garcia, MD (Mexico City, Mexico), Edoardo Baglivo, MD (Geneva, Switzerland), Rubens Belfort, MD, PhD (Sao Paulo, Brazil), Kathleen L. Boldy, DVM (Los Angeles, CA), Chi-Chao Chan, MD (Bethesda, MD), Cristobal A. Couto, MD (Buenos Aires, Argentina), Emmett T. Cunningham, Jr, MD, PhD, MPH (San Francisco, CA), Janet L. Davis, MD (Miami, FL), Marc D. de Smet, MD (Amsterdam, The Netherlands), Emilio M. Dodds, MD (Buenos Aires, Argentina), Kiyoko
References (30)
- et al.
Vogt-Koyanagi-Harada syndrome
Surv Ophthalmol
(1995) - et al.
Vogt-Koyanagi-Harada syndrome after cutaneous injury
Ophthalmology
(1999) - et al.
Role of S-100beta as potential autoantigen in an autoimmune disease of the inner ear
J Neuroimmunol
(1999) - et al.
Clinical significance of HLA-DRB1∗0410 in Japanese patients with idiopathic thrombocytopenic purpura
Blood
(1998) - et al.
Complete association of the HLA-DRB1∗04 and -DQB1∗04 alleles with Vogt-Koyanagi-Harada’s disease
Human Immunol
(1994) - et al.
Association between Vogt-Koyanagi-Harada syndrome and HLA-DR1 and -DR4 in Hispanic patients living in southern California
Ophthalmology
(1995) - et al.
Vogt-Koyanagi-Harada syndrome
Am J Ophthalmol
(1980) - et al.
Anti-retinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, Behcet’s disease, and sympathetic ophthalmia
Ophthalmology
(1985) - et al.
HLA associations and ancestry in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia
Ophthalmology
(1990) - et al.
Unilateral manifestation of the Vogt-Koyanagi-Harada syndrome in a 7-year-old child
Am J Ophthalmol
(1991)
Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease
Am J Ophthalmol
The distribution of melanocytes in the leptomeninges of the human brain
J Invest Dermatol
[Analysis of the candidate antigen for Harada’s disease]
Nippon Ganka Gakkai Zasshi—Acta Societatis Ophthalmologicae Japonicae
Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease
Int Immunol
Cited by (991)
A Novel Risk Stratification-Based Immunomodulatory Treatment Strategy for Vogt-Koyanagi-Harada Disease
2024, American Journal of OphthalmologyVogt-Koyanagi-Harada disease in a patient with extreme anisometropia
2023, American Journal of Ophthalmology Case ReportsBilateral exudative retinal detachments after subretinal gene therapy with voretigene neparvovec-rzyl for RPE65 Leber Congenital Amaurosis
2023, American Journal of Ophthalmology Case Reports
- ☆
This work is supported in part by Research to Prevent Blindness, Inc, New York, New York (Drs Read, Holland, and Rao); the Alabama Eye Institute, Birmingham, Alabama (Dr Read); and the American Ophthalmological Society-Herman Knapp Testimonial Fund 1999–2000 (Dr Read). Dr Holland is a recipient of a Lew R. Wasserman Merit Award from Research to Prevent Blindness, Inc.
- 1
The authors constitute the International Committee on Vogt-Koyanagi-Harada Disease Nomenclature, representing the participants of the First International Workshop on Vogt-Koyanagi-Harada Disease. A full list of participants appears at the end of the article.